Top Stories
-
The most detailed analysis to date of CRISPR genome editing in human embryos finds a significant risk of chromosomal abnormalities when using the technique at the earliest stage of human development.
-
Coronaviruses are adept at mimicking human immune proteins called complement, which may allow the viruses to gain a foothold in our bodies and cause disease.
Topic
-
Columbia/NYSPI researchers are examining how millions of college students are addressing COVID-19 challenges, including academic/life plans, decision-making, substance use, and mental well-being.
Topic
-
Cardiovascular disease is the No. 1 cause of maternal mortality in the United States, but a new study suggests specialized cardio-obstetrics teams may improve outcomes.
Topic
Latest News
- October 19, 2020
New data from Columbia and other ECMO centers throughout the world show that more than 60% of severe COVID-19 patients who receive ECMO, a heart-lung life support machine, survive.
Topic
- October 16, 2020
Using stem cells from pig fat, a team led by Columbia engineers grew anatomically precise jawbones, including associated cartilage, that successfully replaced the pig's temporomandibular joint (TMJ).
Topic
- October 2, 2020
New data mining techniques are uncovering previously hidden adverse drug effects that impact women more than men.
Topic
- September 28, 2020
A new technique developed by experts in electron microscopy can capture a molecule’s most subtle but revealing motions.
- September 8, 2020
Experts on convalescent plasma discuss why randomized clinical trials of the treatment in COVID-19 patients are more important than ever.
Topic
- August 12, 2020
Columbia researchers have uncovered an array of new genes that cause stillbirth, significantly increasing the understanding of the genetic foundations of a common, but little studied, condition.
Topic
- August 3, 2020
New genetic and patient analyses suggest severe COVID is linked to overactive complement, one of the immune system’s oldest branches, and excess blood clotting.
Topic
- July 23, 2020
Columbia's Irving Institute for Clinical and Translational Research selected five new Herbert and Florence Irving Scholars to receive funding for the next three years to support their research.
Topic
- July 22, 2020
Physicians, researchers, and public health experts from Columbia University weigh in on what we now know about the novel coronavirus and what we still need to learn.
Topic
- July 22, 2020
Columbia researchers have isolated antibodies from COVID-19 patients that neutralize SARS-CoV-2 virus and could be used to treat patients or prevent infections.
Topic
